4basebio PLC (AIM:4BB)
London · Delayed Price · Currency is GBP · Price in GBX 970.00
+21.00 (2.16%)
Jul 28, 2025, 4:35 PM GMT+1
4basebio Revenue
In the year 2024, 4basebio had annual revenue of 933.00K GBP with 84.39% growth. 4basebio had revenue of 605.00K in the half year ending December 31, 2024, with 421.55% growth.
Revenue
933.00K
Revenue Growth
+84.39%
P/S Ratio
160.91
Revenue / Employee
8.48K
Employees
110
Market Cap
150.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 933.00K | 427.00K | 84.39% |
| Dec 31, 2023 | 506.00K | 238.00K | 88.81% |
| Dec 31, 2022 | 268.00K | -70.00K | -20.71% |
| Dec 31, 2021 | 338.00K | -124.00K | -26.84% |
| Dec 31, 2020 | 462.00K | -346.00K | -42.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |